Isalon
CAS 5579-81-7
Isalon (CAS 5579-81-7) is a pharmaceutical compound with 0 bioactivity targets and 7 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Isalon is linked to DTXSID8057774 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Isalon used for in pharmaceutical contexts?
Isalon (CAS 5579-81-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Isalon?
Isalon has 7 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Asthma, Decreased appetite, Drug hypersensitivity, Matrix metalloproteinase-3 increased, Mental fatigue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Isalon also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Aldioxa with EU status "permitted".
What clinical phase is Isalon in?
No phase 1-4 clinical development badge is rendered for Isalon because the matched compound identifier rows do not contain a max-phase value.